We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

21 hedge funds and large institutions have $2.83M invested in Aethlon Medical in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

50% more funds holding

Funds holding: 14 → 21 (+7)

0% more ownership

Funds ownership: 0% → 0% (+0%)

32% less capital invested

Capital invested by funds: $4.18M → $2.83M (-$1.34M)

75% less call options, than puts

Call options by funds: $51K | Put options by funds: $200K

Holders
21
Holders Change
+7
Holders Change %
+50%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
1
Closed
1
Calls
$51K
Puts
$200K
Net Calls
-$149K
Net Calls Change
-$162K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$547K
2
Two Sigma Investments
Two Sigma Investments
New York
+$205K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$137K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$125K
5
Citadel Advisors
Citadel Advisors
Florida
+$102K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$101K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$91.1K
3
HI
Harbour Investments
Wisconsin
-$4K

AEMD Hedge Fund Activity: Q4 2021 in Review

21 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2021, worth a combined $2.83M — down 32% from $4.18M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AEMD positions and 1 closed out — a net gain of 7 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $547K. The largest seller was Jane Street, exiting entirely with an estimated $101K sold.

  • 21 institutional investors held Aethlon Medical (AEMD) as of Q4 2021, up from 14 in Q3 2021.
  • Funds reported $2.83M of Aethlon Medical stock for Q4 2021, down 32% quarter-over-quarter.
  • 8 funds opened new Aethlon Medical positions in Q4 2021 and 1 closed out, a net change of +7 holders.
  • The largest Aethlon Medical buyer in Q4 2021 was Renaissance Technologies, an estimated $547K added.
  • The largest Aethlon Medical seller in Q4 2021 was Jane Street, an estimated $101K sold.

Based on aggregated 13F filings for Q4 2021.